Cargando…
Differential Regulation of mTOR Complexes with miR-302a Attenuates Myocardial Reperfusion Injury in Diabetes
Persistent activation of mTOR (mammalian target of rapamycin) in diabetes increases the vulnerability of the heart to ischemia/reperfusion (I/R) injury. We show here that infusion of rapamycin (mTOR inhibitor) at reperfusion following ischemia reduced myocardial infarct size and apoptosis with resto...
Autores principales: | Samidurai, Arun, Ockaili, Ramzi, Cain, Chad, Roh, Sean K., Filippone, Scott M., Kraskauskas, Donatas, Kukreja, Rakesh C., Das, Anindita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725936/ https://www.ncbi.nlm.nih.gov/pubmed/33319180 http://dx.doi.org/10.1016/j.isci.2020.101863 |
Ejemplares similares
-
Preclinical model of type 1 diabetes and myocardial ischemia/reperfusion injury in conscious rabbits—demonstration of cardioprotection with rapamycin
por: Samidurai, Arun, et al.
Publicado: (2021) -
Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit
por: Samidurai, Arun, et al.
Publicado: (2023) -
Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK
por: Filippone, Scott M., et al.
Publicado: (2017) -
Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases
por: Samidurai, Arun, et al.
Publicado: (2018) -
Remote Ischemic Pre-Conditioning Attenuates Adverse Cardiac Remodeling and Mortality Following Doxorubicin Administration in Mice
por: Gertz, Zachary M., et al.
Publicado: (2019)